期刊
JOURNAL OF CHILD NEUROLOGY
卷 24, 期 4, 页码 477-477出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/0883073808324535
关键词
tuberous sclerosis; rapamycin; seizures
资金
- NCRR NIH HHS [KL2 RR024149, KL2 RR024149-05S1] Funding Source: Medline
The authors present a 10-year-old girl with tuberous sclerosis complex who has been receiving rapamycin for 10 months for seizure control. She was started at 0.05 mg/kg/d and titrated to an effective dose of 0.15 mg/kg/d. There was it dramatic reduction in seizure frequency with rapamycin therapy. Further studies are needed to objectively investigate the benefits of rapamycin in tuberous sclerosis complex and to clarify its mechanism of seizure control.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据